Insulin Resistance Intervention After Stroke Trial (IRIS)
This study has been completed.
First Posted: September 22, 2004
Last Update Posted: October 28, 2016
National Institute of Neurological Disorders and Stroke (NINDS)
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):